Literature DB >> 16237275

Multipotential differentiation of adipose tissue-derived stem cells.

Brian M Strem1, Kevin C Hicok, Min Zhu, Isabella Wulur, Zeni Alfonso, Ronda E Schreiber, John K Fraser, Marc H Hedrick.   

Abstract

Tissue engineering offers considerable promise in the repair or replacement of diseased and/or damaged tissues. The cellular component of this regenerative approach will play a key role in bringing these tissue engineered constructs from the laboratory bench to the clinical bedside. However, the ideal source of cells still remains unclear and may differ depending upon the application. Current research for many applications is focused on the use of adult stem cells. The properties of adult stem cells that make them well-suited for regenerative medicine are (1) ease of harvest for autologous transplantation, (2) high proliferation rates for ex vivo expansion and (3) multilineage differentiation capacity. This review will highlight the use of adipose tissue as a reservoir of adult stem cells and draw conclusions based upon comparisons with bone marrow stromal cells.

Mesh:

Substances:

Year:  2005        PMID: 16237275     DOI: 10.2302/kjm.54.132

Source DB:  PubMed          Journal:  Keio J Med        ISSN: 0022-9717


  240 in total

1.  Could fetal fluid and membranes be an alternative source for mesenchymal stem cells (MSCs) in the feline species? A preliminary study.

Authors:  Eleonora Iacono; Marco Cunto; Daniele Zambelli; Francesca Ricci; Pier Luigi Tazzari; Barbara Merlo
Journal:  Vet Res Commun       Date:  2012-02-12       Impact factor: 2.459

2.  Subcutaneous adipocytes may become osteoblasts.

Authors:  Simone Ciuffi; Sergio Fabbri; Roberto Zonefrati; Gianna Galli; Annalisa Tanini; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2012-05-29

Review 3.  The potential of adipose stem cells in regenerative medicine.

Authors:  Bettina Lindroos; Riitta Suuronen; Susanna Miettinen
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

4.  Schwann-like cell differentiation of rat adipose-derived stem cells by indirect co-culture with Schwann cells in vitro.

Authors:  Y Wei; K Gong; Z Zheng; L Liu; A Wang; L Zhang; Q Ao; Y Gong; X Zhang
Journal:  Cell Prolif       Date:  2010-12       Impact factor: 6.831

Review 5.  Adipose mesenchymal stem cells in the field of bone tissue engineering.

Authors:  Cecilia Romagnoli; Maria Luisa Brandi
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

6.  Harvest site influences the growth properties of adipose derived stem cells.

Authors:  Patricia E Engels; Mathias Tremp; Paul J Kingham; Pietro G di Summa; René D Largo; Dirk J Schaefer; Daniel F Kalbermatten
Journal:  Cytotechnology       Date:  2012-10-25       Impact factor: 2.058

7.  Identification of novel stem cell markers using gap analysis of gene expression data.

Authors:  Paul M Krzyzanowski; Miguel A Andrade-Navarro
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

8.  Translational treatment paradigm for managing non-unions secondary to radiation injury utilizing adipose derived stem cells and angiogenic therapy.

Authors:  Alexis Donneys; Jordan T Blough; Noah S Nelson; Joseph E Perosky; Sagar S Deshpande; Stephen Y Kang; Peter A Felice; Christian Figueredo; Jonathan R Peterson; Kenneth M Kozloff; Benjamin Levi; Douglas B Chepeha; Steven R Buchman
Journal:  Head Neck       Date:  2015-07-15       Impact factor: 3.147

9.  Characterization of mechanical and regenerative properties of human, adipose stromal cells.

Authors:  Manisha Kanthilal; Eric M Darling
Journal:  Cell Mol Bioeng       Date:  2014-12       Impact factor: 2.321

10.  Adipose stem cells used to reconstruct 13 cases with cranio-maxillofacial hard-tissue defects.

Authors:  George K Sándor; Jura Numminen; Jan Wolff; Tuomo Thesleff; Aimo Miettinen; Veikko J Tuovinen; Bettina Mannerström; Mimmi Patrikoski; Riitta Seppänen; Susanna Miettinen; Markus Rautiainen; Juha Öhman
Journal:  Stem Cells Transl Med       Date:  2014-02-20       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.